The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosides

Journal of Hepatology

Volumn 28, Issue 2, 1998, Pages 240-249

  Hedman, Ann ^a   Meijer, Dirk K f ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Digoxin; Hepatobiliary transport; Ouabain; Quinidine; Quinine; Rat liver; Stereoselective interactions

Indexed keywords

CARDIAC GLYCOSIDE; CARRIER PROTEIN; DIGOXIN; OUABAIN; QUINIDINE; QUININE; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; DIASTEREOISOMER; DRUG CLEARANCE; DRUG DISPOSITION; DRUG TRANSPORT; DRUG UPTAKE; HEPATOBILIARY SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY; STEREOISOMERISM;

EID: 0032006565     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(88)80011-4     Document Type: Article

References (30)

1. Ejvinsson G. Effect of quinidine on plasma concentrations of digoxin. Br Med J. 1:1978;279-280.
2. Hager WD, Fenster P, Mayersohn M, Perrier D, Graves P, Marcus FI, et al. Digoxin-quinidine interaction. Pharmacokinetic evaluation. N Engl J Med. 300:1979;1238-1241.
3. Dahlqvist R, Ejvinsson G, Schenck-Gustafsson K. Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction. Br J Clin Pharmacol. 9:1980;413-418.
4. Angelin B, Arvidsson A, Dahlqvist R, Hedman A, Schenck-Gustafsson K. Quinidine reduces biliary clearance of digoxin in man. Eur J Clin Invest. 17:1987;262-265.
5. Hedman A, Angelin B, Arvidsson A, Dahlqvist R, Nilsson B. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine. Clin Pharmacol Ther. 47:1990;20-26.
6. Hedman A, Angelin B, Arvidsson A, Beck O, Dahlqvist R, Nilsson B, et al. Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans. Clin Pharmacol Ther. 49:1991;256-262.
7. Meijer DKF, Keulemans K, Mulder GJ. Isolated perfused rat liver technique. Methods Enzymol. 77:1981;81-94.
8. Meijer DKF, Nijssen HMJ. Transport of drugs, proteins and drug-protein conjugates. Ballet F, Thurman RG. Research in Perfused Liver: Clinical and Basic Applications. 1991;165-208 INSERM/John Libbey, London.
9. Wollenweber P. Organische Sorptionsmittel. Stahl E. Dünnschicht-Chromatographie: ein Laboratoriumshandbuch. 1967;33-42 Springer-Verlag, Berlin.
10. Kolenda KD, Lüllmann H, Peters T. Metabolism of cardiac glycosides studied in the isolated perfused guinea-pig liver. Br J Pharmacol. 41:1971;661-673.
11. Drayer DE, Restivo K, Reidenberg MM. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography. J Lab Clin Med. 90:1977;816-822.
12. Okudaira K, Sawada Y, Sugiyama Y, Iga T, Hanano M. Effects of basic drugs on the hepatic transport of cardiac glycosides in rats. Biochem Pharmacol. 37:1988;2949-2955.
13. Hewick DS, Ostenfeld T. The effect of digoxin dosage on the digoxin-quinidine interaction in the bile duct-cannulated rat. J Pharm Pharmacol. 39:1987;64-67.
14. Goodman Gilman A, Rall TW, Nies AS, Taylor P. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 1993;McGraw-Hill, New York.
15. Graf J, Häussinger D. Ion transport in hepatocytes: mechanisms and correlations to cell volume, hormone actions and metabolism. J Hepatol. 24:1996;53-77.
16. Cook NS, Haylett DG. Effects of apamin, quinine and neuromuscular blockers on calcium-activated potassium channels in guinea-pig hepatocytes. J Physiol (Lond). 385:1985;373-394.
17. 3H-ouabain. Drug Metab Dispos. 4:1976;1-7.
18. Hedman A. Inhibition by basic drugs of digoxin secretion into human bile. Eur J Clin Pharmacol. 42:1992;457-459.
19. Kim D-H, Akera T, Brody TM. Tissue binding sites involved in quinidine-cardiac glycoside interactions. J Pharmacol Exp Ther. 218:1981;357-362.
20. Notterman DA, Drayer DE, Metakis L, Reidenberg MM. Stereoselective renal tubular secretion of quinidine and quine. Clin Pharmacol Ther. 40:1986;511-517.
21. Le Corre P, Malledant Y, Chevanne F, Sado P, Le Verge R. Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans. Chirality. 4:1992;80-83.
22. Ben-Itzhak J, Bassan HM, Shor R, Lanir A. Digoxin quinidine interaction: a pharmacokinetic study in the isolated perfused rat liver. Life Sci. 37:1985;411-415.
23. Sato J, Sawada Y, Iga T, Hanano M. Effect of quinidine on digoxin distribution and elimination in guinea pigs. J Pharm Sci. 72:1983;1137-1141.
24. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Keopsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature. 372:1994;549-552.
25. Bossuyt X, Müller M, Meier PJ. Multispecific amphipathic substrate transport by an organic anion transporter of human liver. J Hepatol. 25:1996;733-738.
26. Koepsell H. Organic cation transporters in intestine, kidney, liver and brain. Annu Rev Physiol. 1997;. in press.
27. Bossuyt X, Müller M, Hagenbuch B, Meier PJ. Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. J Pharmacol Exp Ther. 276:1996;891-896.
28. Steen H, Merema M, Meijer DKF. A multispecific uptake system for taurocholate, cardiac glycosides and cationic drugs in the liver. Biochem Pharmacol. 44:1992;2323-2331.
29. Meijer DKF, Mol WEM, Müller M, Kurz G. Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J Pharmacokinet Biopharm. 18:1990;35-70.
30. Meijer DKF, Smit JW, Müller M. Hepatobiliary elimination of cationic drugs: the role of P-glycoproteins and other ATP-dependent transporters. Adv Drug Deliv Rev. 25:1997;159-200.